Near Infrared Spectroscopy to Determine Patent Ductus Arteriosus Closure

Albany Medical College4 enrolled

Overview

Using cerebral and renal near infrared spectroscopy monitoring to determine PDA closure in preterm infants after completing medical treatment for a hemodynamically significant PDA.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Patent Ductus Arteriosus

Interventions

near infrared spectroscopyDEVICE

Near infrared spectroscopy will be placed on infants both with and without hsPDA

Eligibility

Sex: ALLMin age: 1 MinuteMax age: 1 WeekHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * preterm infants less than 32 weeks gestation Exclusion Criteria: * infection, congenital heart disease, syndromic anomalies, and perinatal asphyxia.

Locations (1)

Albany Medical Center Neonatal Intesive Care Unit

Albany, New York, United States

Outcomes

Primary Outcomes

Change in NIRS readings

Time frame: 3 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.